Ossiam Sells 120,378 Shares of Aflac Incorporated (NYSE:AFL)

Ossiam cut its stake in shares of Aflac Incorporated (NYSE:AFL - Free Report) by 54.4% in the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 100,921 shares of the financial services provider's stock after selling 120,378 shares during the quarter. Ossiam's holdings in Aflac were worth $10,439,000 at the end of the most recent reporting period.

A number of other hedge funds have also modified their holdings of the stock. Whipplewood Advisors LLC acquired a new position in shares of Aflac in the 4th quarter valued at $26,000. BankPlus Trust Department acquired a new position in shares of Aflac in the fourth quarter worth about $34,000. Curio Wealth LLC purchased a new position in shares of Aflac in the fourth quarter worth approximately $36,000. OFI Invest Asset Management purchased a new stake in shares of Aflac in the 4th quarter valued at approximately $38,000. Finally, Rialto Wealth Management LLC acquired a new position in Aflac in the 4th quarter worth approximately $41,000. 67.44% of the stock is currently owned by institutional investors and hedge funds.

Insider Transactions at Aflac

In related news, Director Joseph L. Moskowitz sold 1,000 shares of Aflac stock in a transaction dated Friday, March 7th. The stock was sold at an average price of $107.63, for a total transaction of $107,630.00. Following the sale, the director now directly owns 25,393 shares of the company's stock, valued at $2,733,048.59. This trade represents a 3.79 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, Director Charles D. Lake II sold 29,802 shares of the company's stock in a transaction that occurred on Monday, March 10th. The shares were sold at an average price of $107.29, for a total value of $3,197,456.58. Following the completion of the transaction, the director now directly owns 49,962 shares of the company's stock, valued at approximately $5,360,422.98. This trade represents a 37.36 % decrease in their position. The disclosure for this sale can be found here. 0.90% of the stock is currently owned by corporate insiders.

Aflac Stock Performance

Aflac stock traded up $0.71 during trading hours on Thursday, reaching $109.14. 906,906 shares of the company were exchanged, compared to its average volume of 2,117,099. Aflac Incorporated has a 12 month low of $80.59 and a 12 month high of $115.50. The firm has a market cap of $59.57 billion, a price-to-earnings ratio of 11.37, a PEG ratio of 3.24 and a beta of 0.81. The company has a current ratio of 0.10, a quick ratio of 0.08 and a debt-to-equity ratio of 0.29. The stock has a 50-day moving average of $106.95 and a 200 day moving average of $107.18.

Aflac (NYSE:AFL - Get Free Report) last posted its earnings results on Wednesday, February 5th. The financial services provider reported $1.56 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $1.63 by ($0.07). Aflac had a net margin of 28.76% and a return on equity of 16.20%. As a group, research analysts anticipate that Aflac Incorporated will post 6.88 earnings per share for the current year.

Analysts Set New Price Targets

Several analysts have recently commented on the company. Wells Fargo & Company decreased their target price on Aflac from $104.00 to $102.00 and set an "equal weight" rating for the company in a research report on Wednesday, February 19th. Piper Sandler raised their price target on shares of Aflac from $118.00 to $124.00 and gave the stock an "overweight" rating in a report on Wednesday, April 2nd. Barclays dropped their price objective on shares of Aflac from $98.00 to $95.00 and set an "underweight" rating on the stock in a research note on Friday, February 7th. StockNews.com raised shares of Aflac from a "sell" rating to a "hold" rating in a research note on Friday, February 14th. Finally, BMO Capital Markets initiated coverage on shares of Aflac in a research note on Thursday, January 23rd. They issued a "market perform" rating and a $111.00 price target on the stock. Two investment analysts have rated the stock with a sell rating, eleven have assigned a hold rating and two have issued a buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $103.93.

Aflac Profile

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.